GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-repurchase, stock-buyback, transaction-in-own-shares
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on April 14, 2025, that it has purchased a number of its own ordinary shares, each valued at 31 1/4 pence. The transactions were executed through its corporate stockbroker, Citigroup Global Markets Limited.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of share repurchases and does not indicate any new material risks.
Key Numbers
- 31 1/4 pence — Share Value (Nominal value of each ordinary share purchased by GSK.)
Key Players & Entities
- GSK plc (company) — The company making the share repurchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker executing the share repurchase on behalf of GSK.
- 31 1/4 pence (dollar_amount) — The nominal value of each ordinary share purchased.
FAQ
What is the total number of shares GSK purchased?
The filing states that GSK purchased 'the following number' of ordinary shares but does not specify the exact quantity in the provided text.
What is the total value of the share repurchase?
The filing does not provide the total value of the share repurchase, only the nominal value per share.
When did these share purchases take place?
The filing is dated April 14, 2025, and reports on transactions for the month of April 2025, but specific transaction dates are not detailed.
What is the purpose of these share repurchases?
The filing does not explicitly state the purpose of the share repurchases, but it is a transaction in own shares.
Is GSK plc a foreign private issuer?
Yes, the filing is a Form 6-K, which is a 'REPORT OF FOREIGN PRIVATE ISSUER'.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding GSK plc (GLAXF).